Frontlight ResearchEarly access
CompletedNo phase
Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
Key facts
- Who runs it
- Wandercraft
- Where
- France3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 35 people enrolled
- Started
- 1 Jun 2024
- Ended
- 1 Sept 2024
- Type of study
- Observational
- Treatments tested
- Hands-free exoskeleton
- Record updated
- 23 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- ≥18 years old,
- Tetraplegia or high paraplegia (at or above T4) regardless of the cause,
- Non-opposition to the participation to the study,
- Having undergone a minimum of 1 session with the Atalante device from February 2019, to now
Who cannot take part
- Neurological Level of Injury below T4 as determined by the International Standards for Neurological Classification of SCI
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this clinical trial is to determine whether the Atalante X exoskeleton can be safely utilized by patients with tetraplegia and high paraplegia (at or above T4).
The group in the trial
- Hands-free exoskeleton
Patient with high paraplegia or tetraplegia who have undergone at least one session with the exoskeleton.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 April 2025